Showing 5,809 results

Filters Content type: News, Editors' picks Topic: HIV treatment

Treatment is recommended for all people living with HIV. It involves taking a combination of antiretroviral drugs. This stops the virus from replicating and allows the immune system to strengthen and fight infections.

PrEP science

Older age and baseline kidney function are the key risk factors for renal dysfunction while taking HIV PrEP

News
23 March 2020
Treatment outcomes & life expectancy

Doubled Risk of non-HIV Mortality in US People at Risk for HIV

Editor's pick
NATAP
20 March 2020
Retention & linkage to care

Adherence clubs linked to 30% reduction in high viral load among postpartum South African women living with HIV

News
19 March 2020
Weight gain & lipodystrophy

Weight gain after starting HIV treatment may have genetic influences

News
18 March 2020
HIV treatment for children & young people

New approaches for paediatric dosing: abacavir in newborns, doubling dolutegravir with rifampicin

News
18 March 2020
Coronavirus

J&J warns doctors not to count on Prezista as a COVID-19 treatment

Editor's pick
FiercePharma
17 March 2020
Weight gain & lipodystrophy

New mothers with HIV gain more weight on dolutegravir than efavirenz

News
17 March 2020
Treatment outcomes & life expectancy

Yes, the same life expectancy as HIV-negative people, but far fewer years in good health

News
13 March 2020
PrEP science

Taking PrEP during acute HIV infection for more than 2-3 weeks is likely to cause resistance, Thai study finds

News
13 March 2020
Coronavirus

South Korea experts recommend anti-HIV, anti-malaria drugs for COVID-19

Editor's pick
UPI
13 March 2020
New & experimental HIV treatments

Long-acting capsid inhibitor GS-6207 confirms safety and antiviral activity

News
12 March 2020
The search for an HIV prevention vaccine

HIV vaccine that generates broadly neutralising antibodies passes first safety and proof-of-concept study in humans

News
12 March 2020
Bad science & bogus treatments

HIV conspiracy theories and the virus continue to thrive in Russia

Editor's pick
Los Angeles Times
12 March 2020
Treatment for women

Dolutegravir-based HIV treatment is the safest and most effective choice for pregnant women

News
12 March 2020
Injectable & long-acting HIV treatment

Long-acting injectables might be administered every two months

News
11 March 2020
Cardiovascular disease

Weight gain on antiretroviral treatment raises risk of diabetes

News
11 March 2020
The search for a cure

Safety and PK of bNAb elipovimab (GS-9722) support two-weekly dosing

Editor's pick
i-Base
10 March 2020
Heterosexual men

Community-based HIV treatment superior to clinic-based care for men in South Africa

News
9 March 2020
Retention & linkage to care

Good retention in care with six-monthly clinic visits in Lesotho

News
9 March 2020
PrEP policies & guidelines

Far fewer people would get PrEP in the US if generic TDF/FTC is replaced with Descovy (TAF/FTC), cost-effectiveness study finds

News
9 March 2020
PrEP science

Uptick in Statin Use After Descovy in HIV PrEP

Editor's pick
Medscape (requires free registration)
9 March 2020
Bad science & bogus treatments

They’re Still Here! Scary HIV Ads on Facebook Won’t Go Away

Editor's pick
POZ
5 March 2020
The search for a cure

HIV reservoirs in humans: Immediate antiretroviral therapy makes them 100 times smaller

Editor's pick
EurekAlert
5 March 2020
Treatment guidelines

South Africa: Health Department’s dolutegravir plans hit stumbling block

Editor's pick
MedicalBrief
2 March 2020